[HTML][HTML] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S Evers, A Ament, GL Colombo, HB Konradsen… - European Journal of …, 2007 - Springer
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

S Evers, A Ament, GL Colombo, HB Konradsen… - 2007 - cabidigitallibrary.org
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

[引用][C] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

SMAA EVERS, AJHA AMENT… - European journal of …, 2007 - pascal-francis.inist.fr
Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease
in the elderly : an update for 10 Western European countries CNRS Inist Pascal-Francis CNRS …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

S Evers, A Ament, GL Colombo… - … Journal of Clinical …, 2007 - search.ebscohost.com
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

[PDF][PDF] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S Evers, A Ament, GL Colombo… - Eur J Clin Microbiol …, 2007 - researchgate.net
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

A Evers, A Ament, GL Colombo… - … Journal of Clinical …, 2007 - search.proquest.com
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S Evers, A Ament, GL Colombo… - … journal of clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults>
or= 65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

SM Evers, AJ Ament, GL Colombo… - European Journal of …, 2007 - europepmc.org
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults>
or= 65 years of age, but it is not widely used in Western Europe. In this study, data from an …

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S Evers, A Ament, GL Colombo, HB Konradsen… - European Journal of …, 2007 - infona.pl
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …

[PDF][PDF] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S Evers, A Ament, GL Colombo… - Eur J Clin Microbiol …, 2007 - academia.edu
Pneumococcal vaccine is effective in preventing invasive pneumococcal disease in adults≥
65 years of age, but it is not widely used in Western Europe. In this study, data from an …